Beranda › Diabetes Tipe 2
Uji klinis Diabetes Tipe 2 yang merekrut di AS
240 studi untuk Diabetes Tipe 2 merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- San Antonio, TX37 studi
- Houston, TX31 studi
- Orlando, FL24 studi
- Boston, MA20 studi
- Miami, FL19 studi
- Dallas, TX19 studi
- Chicago, IL19 studi
- Columbus, OH18 studi
- Las Vegas, NV18 studi
- San Diego, CA17 studi
- Atlanta, GA17 studi
- New York City, NY16 studi
- Los Angeles, CA16 studi
- Birmingham, AL16 studi
- Arlington, VA15 studi
- Philadelphia, PA15 studi
- Jacksonville, FL15 studi
- Havelock, NC13 studi
- Washington, DC12 studi
- Austin, TX12 studi
- Indianapolis, IN12 studi
- Cincinnati, OH12 studi
- Kansas City, MO11 studi
- Long Beach, CA11 studi
- Durham, NC11 studi
- Albuquerque, NM11 studi
- Salt Lake City, UT11 studi
- Aurora, CO11 studi
- Omaha, NE11 studi
- Deltona, FL10 studi
- Pittsburgh, PA10 studi
- Oklahoma City, OK10 studi
- Tucson, AZ10 studi
- Concord, CA10 studi
- Little Rock, AR10 studi
- Wichita, KS10 studi
- Ann Arbor, MI10 studi
- Hialeah, FL10 studi
- New Haven, CT10 studi
- Baltimore, MD10 studi
Berdasarkan negara bagian
- Alabama22 studi
- Arizona22 studi
- Arkansas11 studi
- California67 studi
- Colorado16 studi
- Connecticut14 studi
- Distrik Columbia7 studi
- Florida48 studi
- Georgia34 studi
- Hawaii7 studi
- Idaho12 studi
- Illinois30 studi
- Indiana18 studi
- Iowa10 studi
- Kansas15 studi
- Kentucky12 studi
- Louisiana15 studi
- Maryland26 studi
- Massachusetts29 studi
- Michigan27 studi
- Minnesota17 studi
- Mississippi9 studi
- Missouri20 studi
- Montana4 studi
- Nebraska14 studi
- Nevada18 studi
- New Jersey15 studi
- New Mexico12 studi
- New York33 studi
- North Carolina36 studi
- North Dakota6 studi
- Ohio41 studi
- Oklahoma13 studi
- Oregon7 studi
- Pennsylvania30 studi
- Rhode Island3 studi
- South Carolina20 studi
- South Dakota3 studi
- Tennessee18 studi
- Texas58 studi
- Utah19 studi
- Virginia26 studi
- Washington20 studi
- West Virginia7 studi
- Wisconsin9 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06906627Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06906640A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07817251A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07564414A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 29 Sep 2026 · NCT05909046NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06593327A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07223333A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Menerima pesertaSukarelawan sehat diterima
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06112418Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06836479Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07399678A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07776509ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Menerima peserta
Usia 8 hingga 21 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05463289Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02969798A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07784270Phenotyping Genetic Risk for Type 2 Diabetes
Menerima pesertaSukarelawan sehat diterima
Usia 10 hingga 70 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT04024631Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07494084Improving the Collaborative Health of Adult Dyads
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05370014Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 12 hingga 25 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06730113Plant-Based Online Weight Loss Through Education and Resources Program and Study
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07095543A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07723833Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.